• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: JOHNSON & JOHNSON VISION CARE ¿ IRELAND 1-DAY ACUVUE TRUEYE (NARA A); LENSES, SOFT CONTACT, DAILY WEAR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

JOHNSON & JOHNSON VISION CARE ¿ IRELAND 1-DAY ACUVUE TRUEYE (NARA A); LENSES, SOFT CONTACT, DAILY WEAR Back to Search Results
Catalog Number 1D4
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Corneal Ulcer (1796); Corneal Clouding/Hazing (1878); Pain (1994)
Event Date 09/13/2019
Event Type  Injury  
Event Description
On (b)(6) 2019, a call was placed to the pt who reported that on (b)(6) 2019, the pt experienced pain in the right eye (od).The pt called the treating eye care provider (ecp) from a previous corneal ulcer event for od (reported in mdr # 9617710-2019-00033 on (b)(6) 2019), and the treating ecp advised the pt to resume the same previously prescribed treatment and discontinue cl wear until the issue resolves.The pt was previously prescribed ofloxacin every 2 hours for the first day, then 4 times a day for 7 days.The pt is currently on the third day of treatment and reported that the od is better.The pt noted no longer experiencing any pain.The pt does not have any follow-up appointment scheduled.The pt reports a daily wear schedule and does not sleep in cls or use any solution to clean cls.No further information was provided.On (b)(6) 2019, a call was placed to the treating ecp and additional information was provided: visit on (b)(6) 2019: the pt was diagnosed with central corneal ulcer at inferior nasal to visual axis; corneal ulcer was on the od and roughly the same spot as the previous corneal ulcer; pt was treated with 0.3% ofloxacin q2h for the first day then qid for 1 week.The ecp noticed some haze but thinks it will clear over time.The pt does not have a follow-up appointment scheduled.No further information was provided.No additional information has been received.The suspect od cl is not available for return.A lot history review was performed and revealed the following: the batch record did not show any abnormalities in monomer and solution testing.All parameters tested were within specification.All sterilization requirements were successfully completed.Lot 5358090102 was produced under normal conditions.If any further relevant information is received, a supplemental report will be filed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
1-DAY ACUVUE TRUEYE (NARA A)
Type of Device
LENSES, SOFT CONTACT, DAILY WEAR
Manufacturer (Section D)
JOHNSON & JOHNSON VISION CARE ¿ IRELAND
one technological park plassey
limerick
EI 
Manufacturer Contact
rose harrell
7500 centurion parkway
jacksonville, FL 32256
9044433364
MDR Report Key9175293
MDR Text Key173187712
Report Number9617710-2019-00034
Device Sequence Number1
Product Code LPL
Combination Product (y/n)Y
Reporter Country CodeUS
PMA/PMN Number
K073485
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type consumer,health professional
Reporter Occupation Other
Type of Report Initial
Report Date 09/16/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/10/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Expiration Date10/01/2023
Device Catalogue Number1D4
Device Lot Number5358090102
Was Device Available for Evaluation? No
Date Manufacturer Received09/16/2019
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured10/23/2018
Is the Device Single Use? Yes
Type of Device Usage N
Patient Sequence Number1
Patient Outcome(s) Other; Required Intervention;
Patient Age34 YR
-
-